| |
| |
|
| Insider
Information: |
Crutchfield Bradford |
| Relationship: |
Chief Commercial Officer |
| City: |
Hercules |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
102,569 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,503,677 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
102,569 |
|
|
| Total
Value |
$1,503,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bio Rad Laboratories Inc |
BIO |
Executive Vice President |
2014-06-10 |
5,332 |
2004-02-02 |
0 |
Premium* |
|
|
10x Genomics, Inc. |
TXG |
Chief Commercial Officer |
2022-05-23 |
97,237 |
2020-03-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-05-12 |
4 |
AS |
$133.86 |
$2,291,221 |
D/D |
(17,000) |
34,608 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2020-11-02 |
4 |
AS |
$135.29 |
$1,432,288 |
D/D |
(10,504) |
963 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2020-11-03 |
4 |
AS |
$135.42 |
$891,227 |
D/D |
(6,496) |
963 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-12-13 |
4 |
AS |
$137.63 |
$2,369,096 |
D/D |
(17,000) |
43,055 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-01-04 |
4 |
AS |
$138.97 |
$2,378,773 |
D/D |
(17,000) |
34,608 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2020-12-01 |
4 |
AS |
$150.02 |
$2,571,982 |
D/D |
(17,000) |
963 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-03-12 |
4 |
AS |
$154.52 |
$2,669,218 |
D/D |
(17,000) |
34,608 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-10-12 |
4 |
AS |
$156.49 |
$2,674,153 |
D/D |
(17,000) |
43,336 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-08-12 |
4 |
AS |
$157.19 |
$2,714,681 |
D/D |
(17,000) |
43,606 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-08-23 |
4 |
S |
$161.85 |
$43,699 |
D/D |
(270) |
43,336 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-05-24 |
4 |
S |
$162.66 |
$45,707 |
D/D |
(281) |
43,262 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-09-13 |
4 |
AS |
$169.06 |
$2,966,312 |
D/D |
(17,000) |
43,336 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-02-01 |
4 |
AS |
$173.99 |
$2,991,765 |
D/D |
(17,000) |
34,608 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-04-12 |
4 |
AS |
$181.10 |
$3,160,053 |
D/D |
(17,000) |
34,608 |
0 |
- |
|
| TXG |
10x Genomics, Inc. |
Chief Commercial Officer |
• – – |
2021-07-12 |
4 |
AS |
$185.07 |
$3,170,996 |
D/D |
(17,000) |
43,606 |
0 |
- |
|
90 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
